Lung Allograft Rejection

Deborah J. Levine, Ramsey R. Hachem

Resultado de la investigación: Review articlerevisión exhaustiva

1 Cita (Scopus)

Resumen

Rejection is a major complication following lung transplantation. Acute cellular rejection (ACR), and antibody-mediated rejection (AMR) are risk factors for the subsequent development of chronic lung allograft dysfunction and worse outcomes after transplantation. Although ACR has well-defined histopathologic diagnostic criteria and grading, the diagnosis of AMR requires a multidisciplinary diagnostic approach. This article reviews the identification, clinical and pathologic features of, and therapeutic options for ACR and AMR.

Idioma originalEnglish (US)
Páginas (desde-hasta)221-229
Número de páginas9
PublicaciónThoracic Surgery Clinics
Volumen32
N.º2
DOI
EstadoPublished - may. 1 2022

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine

Huella

Profundice en los temas de investigación de 'Lung Allograft Rejection'. En conjunto forman una huella única.

Citar esto